News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,383 Results
Type
Article (53059)
Company Profile (267)
Press Release (722044)
Multimedia
Podcasts (121)
Webinars (23)
Section
Business (213378)
Career Advice (2165)
Deals (36794)
Drug Delivery (144)
Drug Development (84410)
Employer Resources (175)
FDA (17399)
Job Trends (15905)
News (361778)
Policy (34987)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2861)
Accelerated approval (55)
ADA (44)
Adcomms (34)
Allergies (201)
Alliances (51837)
ALS (235)
Alzheimer's disease (1916)
Antibody-drug conjugate (ADC) (534)
Approvals (17873)
Artificial intelligence (774)
ASCO (334)
Autoimmune disease (358)
Automation (66)
Bankruptcy (377)
Best Places to Work (12129)
BIO (67)
BIOSECURE Act (20)
Biosimilars (238)
Biotechnology (170)
Bladder cancer (207)
Brain cancer (79)
Breast cancer (825)
Cancer (6467)
Cardiovascular disease (527)
Career advice (1850)
Career pathing (49)
CAR-T (362)
CDC (65)
Celiac Disease (3)
Cell therapy (983)
Cervical cancer (58)
Clinical research (73703)
Collaboration (2297)
Commercialization (1)
Company closure (5)
Compensation (1507)
Complete response letters (88)
COVID-19 (2899)
CRISPR (118)
C-suite (1295)
Cystic fibrosis (157)
Data (8778)
Decentralized trials (3)
Denatured (46)
Depression (187)
Dermatology (100)
Diabetes (683)
Diagnostics (7270)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (371)
Drug pricing (213)
Drug shortages (34)
Duchenne muscular dystrophy (310)
Earnings (94496)
Editorial (73)
Employer branding (21)
Employer resources (156)
Events (126047)
Executive appointments (1173)
FDA (21546)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1911)
Gene editing (252)
Generative AI (70)
Gene therapy (769)
GLP-1 (1166)
Government (5058)
Grass and pollen (6)
Guidances (424)
Healthcare (20297)
Hematology (195)
HIV (94)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (112)
Immunology and inflammation (310)
Immuno-oncology (109)
Indications (224)
Infectious disease (3279)
Inflammatory bowel disease (231)
Inflation Reduction Act (14)
Influenza (147)
Intellectual property (322)
Interviews (337)
IPO (17057)
IRA (51)
Job creations (4070)
Job search strategy (1531)
JPM (59)
Kidney cancer (22)
Labor market (113)
Layoffs (597)
Leadership (47)
Legal (8524)
Liver cancer (107)
Longevity (36)
Lung cancer (858)
Lymphoma (480)
Machine learning (67)
Management (61)
Manufacturing (1186)
Marketing (4)
MASH (216)
Medical affairs (1)
Medical device (15052)
Medtech (15234)
Mergers & acquisitions (21072)
Metabolic disorders (1714)
mRNA (243)
Multiple sclerosis (203)
NASH (17)
Neurodegenerative disease (479)
Neuropsychiatric disorders (116)
Neuroscience (3612)
Neurotech (1)
NextGen: Class of 2026 (6964)
Non-profit (4823)
Now hiring (83)
Obesity (795)
Opinion (329)
Ovarian cancer (245)
Pain (274)
Pancreatic cancer (361)
Parkinson's disease (408)
Partnered (37)
Patents (650)
Patient recruitment (793)
Peanut (69)
People (63024)
Pharmaceutical (60)
Pharmacy benefit managers (35)
Phase 1 (22954)
Phase 2 (32394)
Phase 3 (24161)
Pipeline (10026)
Policy (342)
Postmarket research (2756)
Preclinical (9817)
Press Release (67)
Prostate cancer (344)
Psychedelics (61)
Radiopharmaceuticals (359)
Rare diseases (1215)
Real estate (6380)
Recruiting (71)
Regulatory (27410)
Reports (57)
Research institute (2607)
Resumes & cover letters (370)
Rett syndrome (46)
RNA editing (25)
RSV (93)
Schizophrenia (190)
Series A (322)
Series B (238)
Service/supplier (12)
Sickle cell disease (124)
Special edition (25)
Spinal muscular atrophy (174)
Sponsored (51)
Startups (3911)
State (2)
Stomach cancer (19)
Supply chain (141)
Tariffs (90)
The Weekly (73)
Vaccines (1209)
Venture capital (125)
Weight loss (524)
Women's health (144)
Worklife (21)
Date
Today (107)
Last 7 days (519)
Last 30 days (2414)
Last 365 days (31156)
2026 (16712)
2025 (30973)
2024 (36103)
2023 (41173)
2022 (52421)
2021 (57146)
2020 (55981)
2019 (48910)
2018 (37048)
2017 (33841)
2016 (33678)
2015 (39741)
2014 (33454)
2013 (28779)
2012 (31068)
2011 (31677)
2010 (30044)
Location
Africa (829)
Alabama (95)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (43326)
Australia (7163)
California (14201)
Canada (4002)
China (1563)
Colorado (617)
Connecticut (636)
Delaware (441)
Europe (94790)
Florida (2141)
Georgia (458)
Hawaii (3)
Idaho (67)
Illinois (1218)
India (100)
Indiana (646)
Iowa (25)
Japan (612)
Kansas (137)
Kentucky (53)
Louisiana (60)
Maine (76)
Maryland (1715)
Massachusetts (10261)
Michigan (391)
Minnesota (789)
Mississippi (7)
Missouri (152)
Montana (33)
Nebraska (30)
Nevada (155)
New Hampshire (90)
New Jersey (3747)
New Mexico (33)
New York (3747)
North Carolina (1863)
North Dakota (9)
Northern California (7172)
Ohio (426)
Oklahoma (24)
Oregon (42)
Pennsylvania (2814)
Puerto Rico (32)
Rhode Island (54)
South America (1212)
South Carolina (89)
South Dakota (2)
Southern California (5631)
Tennessee (237)
Texas (2301)
United States (50522)
Utah (423)
Vermont (2)
Virginia (354)
Washington D.C. (84)
Washington State (1160)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
775,383 Results for "shape memory medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HSS Study Reveals How Early-Life Cellular Process Helps Shape Lifelong Immune Health
June 28, 2026
·
4 min read
Neurodegenerative disease
VectorY Bets up to $1.2B+ That Shape’s Brain-Penetrant Capsids Are a Fit
VectorY Therapeutics will evaluate the use of SHP-DB1, a capsid developed by Shape Therapeutics, to deliver therapies to the brain, including VectorY’s developmental Huntington’s and Alzheimer’s disease treatments.
September 18, 2025
·
2 min read
·
Dan Samorodnitsky
Biotech Bay
Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization
Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced today that it has completed $38 million in Series C financing.
March 4, 2024
·
4 min read
Biotech Bay
Shape Memory Medical Announces First Patient Treated in the AAA-SHAPE Randomized Controlled Pivotal Trial
Shape Memory Medical Inc. announced the first patient treated as part of the AAA-SHAPE Pivotal Trial, the Company’s prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the IMPEDE-FX RapidFill® Device to improve abdominal aortic aneurysm (AAA) sac behavior when used with elective endovascular aneurysm repair (EVAR).
June 3, 2024
·
3 min read
Press Releases
Ivonescimab Included in FirstWord Pharma’s “The Drugs That Will Shape 2026"
January 29, 2026
·
4 min read
Press Releases
Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026
April 19, 2026
·
5 min read
Press Releases
Shape Memory Medical Announces European Enrollment in the AAA-SHAPE Randomized Controlled Pivotal Trial
February 20, 2025
·
3 min read
Press Releases
TPX-100: OrthoTrophix Presents New Data Revealing Structural Coupling between Femoral Bone Shape and Meniscal Pathology in Knee Osteoarthritis
April 24, 2026
·
4 min read
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.
March 25, 2026
·
2 min read
·
Annalee Armstrong
Manufacturing
Radiopharmaceutical Sector Shapes Supply Chain Around Fast-Decaying Products
The necessity of delivering medicine days after it’s produced drives decisions about where to build facilities and how to ship radioactive materials to healthcare providers.
February 24, 2026
·
3 min read
·
Nick Paul Taylor
1 of 77,539
Next
